These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

568 related articles for article (PubMed ID: 28506242)

  • 1. An imprinted non-coding genomic cluster at 14q32 defines clinically relevant molecular subtypes in osteosarcoma across multiple independent datasets.
    Hill KE; Kelly AD; Kuijjer ML; Barry W; Rattani A; Garbutt CC; Kissick H; Janeway K; Perez-Atayde A; Goldsmith J; Gebhardt MC; Arredouani MS; Cote G; Hornicek F; Choy E; Duan Z; Quackenbush J; Haibe-Kains B; Spentzos D
    J Hematol Oncol; 2017 May; 10(1):107. PubMed ID: 28506242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imprinting defects at human 14q32 locus alters gene expression and is associated with the pathobiology of osteosarcoma.
    Shu J; Li L; Sarver AE; Pope EA; Varshney J; Thayanithy V; Spector L; Largaespada DA; Steer CJ; Subramanian S
    Oncotarget; 2016 Apr; 7(16):21298-314. PubMed ID: 26802029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of miRNA-gene expression-genomic profiles reveals complex mechanisms of microRNA deregulation in osteosarcoma.
    Maire G; Martin JW; Yoshimoto M; Chilton-MacNeill S; Zielenska M; Squire JA
    Cancer Genet; 2011 Mar; 204(3):138-46. PubMed ID: 21504713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs at the human 14q32 locus have prognostic significance in osteosarcoma.
    Sarver AL; Thayanithy V; Scott MC; Cleton-Jansen AM; Hogendoorn PC; Modiano JF; Subramanian S
    Orphanet J Rare Dis; 2013 Jan; 8():7. PubMed ID: 23311495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A MicroRNA cluster at 14q32 drives aggressive lung adenocarcinoma.
    Nadal E; Zhong J; Lin J; Reddy RM; Ramnath N; Orringer MB; Chang AC; Beer DG; Chen G
    Clin Cancer Res; 2014 Jun; 20(12):3107-17. PubMed ID: 24833665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA Methylation Controls Metastasis-Suppressive 14q32-Encoded miRNAs.
    Oshima G; Poli EC; Bolt MJ; Chlenski A; Forde M; Jutzy JMS; Biyani N; Posner MC; Pitroda SP; Weichselbaum RR; Khodarev NN
    Cancer Res; 2019 Feb; 79(3):650-662. PubMed ID: 30538122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variants in the 14q32 miRNA cluster are associated with osteosarcoma risk in the Spanish population.
    Martin-Guerrero I; Bilbao-Aldaiturriaga N; Gutierrez-Camino A; Santos-Zorrozua B; Dolžan V; Patiño-Garcia A; Garcia-Orad A
    Sci Rep; 2018 Oct; 8(1):15414. PubMed ID: 30337581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global, cancer-specific microRNA cluster hypomethylation was functionally associated with the development of non-B non-C hepatocellular carcinoma.
    Nojima M; Matsui T; Tamori A; Kubo S; Shirabe K; Kimura K; Shimada M; Utsunomiya T; Kondo Y; Iio E; Naito Y; Ochiya T; Tanaka Y
    Mol Cancer; 2016 Apr; 15(1):31. PubMed ID: 27137948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perturbation of 14q32 miRNAs-cMYC gene network in osteosarcoma.
    Thayanithy V; Sarver AL; Kartha RV; Li L; Angstadt AY; Breen M; Steer CJ; Modiano JF; Subramanian S
    Bone; 2012 Jan; 50(1):171-81. PubMed ID: 22037351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of imprinting at the 14q32 domain is associated with microRNA overexpression in acute promyelocytic leukemia.
    Manodoro F; Marzec J; Chaplin T; Miraki-Moud F; Moravcsik E; Jovanovic JV; Wang J; Iqbal S; Taussig D; Grimwade D; Gribben JG; Young BD; Debernardi S
    Blood; 2014 Mar; 123(13):2066-74. PubMed ID: 24493669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insights into the imprinted MEG8-DMR in 14q32 and clinical and molecular description of novel patients with Temple syndrome.
    Beygo J; Küchler A; Gillessen-Kaesbach G; Albrecht B; Eckle J; Eggermann T; Gellhaus A; Kanber D; Kordaß U; Lüdecke HJ; Purmann S; Rossier E; van de Nes J; van der Werf IM; Wenzel M; Wieczorek D; Horsthemke B; Buiting K
    Eur J Hum Genet; 2017 Aug; 25(8):935-945. PubMed ID: 28635951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel deletions affecting the MEG3-DMR provide further evidence for a hierarchical regulation of imprinting in 14q32.
    Beygo J; Elbracht M; de Groot K; Begemann M; Kanber D; Platzer K; Gillessen-Kaesbach G; Vierzig A; Green A; Heller R; Buiting K; Eggermann T
    Eur J Hum Genet; 2015 Feb; 23(2):180-8. PubMed ID: 24801763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paternal uniparental disomy chromosome 14-like syndrome due a maternal de novo 160 kb deletion at the 14q32.2 region not encompassing the IG- and the MEG3-DMRs: Patient report and genotype-phenotype correlation.
    Corsello G; Salzano E; Vecchio D; Antona V; Grasso M; Malacarne M; Carella M; Palumbo P; Piro E; Giuffrè M
    Am J Med Genet A; 2015 Dec; 167A(12):3130-8. PubMed ID: 26333487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing of a large microRNA cluster on human chromosome 14q32 in melanoma: biological effects of mir-376a and mir-376c on insulin growth factor 1 receptor.
    Zehavi L; Avraham R; Barzilai A; Bar-Ilan D; Navon R; Sidi Y; Avni D; Leibowitz-Amit R
    Mol Cancer; 2012 Jul; 11():44. PubMed ID: 22747855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of long non-coding RNA MEG3 in nasopharyngeal carcinoma.
    Chak WP; Lung RW; Tong JH; Chan SY; Lun SW; Tsao SW; Lo KW; To KF
    Mol Carcinog; 2017 Mar; 56(3):1041-1054. PubMed ID: 27597634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization- and mutation-dependent microRNA (miRNA) expression signatures in gastrointestinal stromal tumours (GISTs), with a cluster of co-expressed miRNAs located at 14q32.31.
    Haller F; von Heydebreck A; Zhang JD; Gunawan B; Langer C; Ramadori G; Wiemann S; Sahin O
    J Pathol; 2010 Jan; 220(1):71-86. PubMed ID: 19768731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Micro-RNA profiles in osteosarcoma as a predictive tool for ifosfamide response.
    Gougelet A; Pissaloux D; Besse A; Perez J; Duc A; Dutour A; Blay JY; Alberti L
    Int J Cancer; 2011 Aug; 129(3):680-90. PubMed ID: 20949564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imprinting defects in osteosarcoma: DNA- and chromatin-modifying drugs hold promise for osteosarcoma therapy.
    Sarver AE; Subramanian S
    Epigenomics; 2016 Jul; 8(7):885-8. PubMed ID: 27366930
    [No Abstract]   [Full Text] [Related]  

  • 19. Male-specific coordinated changes in expression of miRNA genes, but not other genes within the DLK1-DIO3 locus in multiple sclerosis.
    Baulina N; Kiselev I; Kozin M; Kabaeva A; Boyko A; Favorova O
    Gene; 2022 Aug; 836():146676. PubMed ID: 35714798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and Molecular Analysis of Pathologic Fracture-associated Osteosarcoma: MicroRNA profile Is Different and Correlates with Prognosis.
    Lozano Calderón SA; Garbutt C; Kim J; Lietz CE; Chen YL; Bernstein K; Chebib I; Nielsen GP; Deshpande V; Rubio R; Wang YE; Quackenbush J; Delaney T; Raskin K; Schwab J; Cote G; Spentzos D
    Clin Orthop Relat Res; 2019 Sep; 477(9):2114-2126. PubMed ID: 31389890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.